SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

BRIEF-Hoth Therapeutics Announces Extension Of Washington University Alzheimer's Mouse Model Study With Alzheimer's Therapeutic Ht-Alz

reuters.com · 06/09/2022 08:19
BRIEF-Hoth Therapeutics Announces Extension Of Washington University Alzheimer's Mouse Model Study With Alzheimer's Therapeutic Ht-Alz

- Hoth Therapeutics Inc HOTH:

  • HOTH THERAPEUTICS ANNOUNCES EXTENSION OF WASHINGTON UNIVERSITY ALZHEIMER'S MOUSE MODEL STUDY WITH ALZHEIMER'S THERAPEUTIC HT-ALZ

  • HOTH THERAPEUTICS INC - FOCUS OF NEW STUDIES IS TO DETERMINE A HUMAN EQUIVALENT DOSE OF HT-ALZ FOR STARTING HUMAN CLINICAL TRIALS

Source text for Eikon: ID:nPn10ZHsva

Further company coverage: HOTH


((reuters.briefs@thomsonreuters.com;))